NCT03363295View on ClinicalTrials.gov

Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
EndophthalmitisMacula EdemaCataract
Interventions
DRUG

Moxifloxacin Injection

One group will receive moxifloxacin injection (0,03ml) in the anterior chamber by the end of phacoemulsification surgery

Trial Locations (1)

13083888

Hospital das Clínicas da UNICAMP, Campinas

All Listed Sponsors
lead

Universidade Federal de Pernambuco

OTHER

NCT03363295 - Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis | Biotech Hunter | Biotech Hunter